SPX -0.03% VIX -0.14%
DOW INDUSTRIALS DOWN 130 POINTS AS THURSDAY STOCK-MARKET DECLINES STEEPEN 
FOR THE DOW EARLY THURSDAY, IBM AND UNITEDHEALTH ARE EQUAL, OPPOSING FORCES 
U.S. STOCKS ON TRACK THURSDAY MORNING FOR THIRD STRAIGHT DOWN DAY 
PHILLY FED MANUFACTURING GAUGE REBOUNDS IN JULY 
OIL PRICES RISE OFF 2-WEEK LOWS AS IRAN SEIZES TANKER, LEVELS SMUGGLING CHARGE 
SCHUMER ASKS FBI TO INVESTIGATE FACEAPPS POTENTIAL KREMLIN TIES 
U.S. FIRST-TIME UNEMPLOYMENT CLAIMS ON RISE IN MID-JULY 
APPLE UPGRADE BY RAYMOND JAMES CITES 5G IPHONE PROSPECTS 
NEED TO KNOW: ENERGY STOCKS COULD DOUBLE BY NEXT SUMMER, SAYS CONTRARIAN 
EFFORT TO REDUCE NO-SHOWS FOR CFA EXAM FALLING SHORT: FINANCIAL NEWS 
Thu, Jul 18 1:36pm


Regeneron Pharmaceuticals Inc [REGN]
$300.58 1.16 (0.39%)

REGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 32.08 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.


Visit Website

REGN Earnings

EPS 4.23 P/E Ratio 24.20
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 6, 2019 (In 19 days)

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

$288.00
52 Week Range
$440.05
Jul 11, 2019
Mar 1, 2019



Symbol Price Day % YTD %
REGN $300.58 0.39% -19.29%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy